Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

An increasing number of women are diagnosed with cancer during pregnancy and lactation. Women are usually advised to interrupt breastfeeding during systemic anticancer treatment for fear of serious adverse effects to the nursed infant. However, the issue is poorly addressed in the literature and very few studies have evaluated the safety of breastfeeding during or after cytotoxic drugs or target agents administration. In this review we will analyze the available evidence that addresses the issue of anticancer drugs, targeted agents, antiemetics and growth-factors excretion in human milk. This could serve as a unique resource that may aid physicians in the management of breastfeeding cancer patients interested in maintaining lactation during treatment. Copyright © 2012 Elsevier Ltd. All rights reserved.


Barbara Pistilli, Giulia Bellettini, Elisa Giovannetti, Giovanni Codacci-Pisanelli, Hatem A Azim, Giovanni Benedetti, Maria Anna Sarno, Fedro A Peccatori. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding? Cancer treatment reviews. 2013 May;39(3):207-11

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 23199900

View Full Text